Data / Research funding / Kamuzu University of Health Sciences
Kamuzu University of Health Sciences: 6 NIH awards ($3.2M), fiscal years 2021 to 2026
Kamuzu University of Health Sciences in Blantyre is funded under 6 NIH awards ($3.2M) in the NIH and NSF award files, read 2026-11-04. NIH fiscal years 2021 to 2025; NSF fiscal years 2022 to 2026.
SpecStream is the live web data engine for teams and agents. It reads the NIH and NSF award files each time the agencies update them, and this page is that reading, joined to the open federal funding opportunities on Grants.gov. Ask for the awards you track by topic, organization or state and new awards arrive in your sheet, CRM, Slack or agent as the agencies publish them.
- E7PXR3Q3LWJ4UEI
Awards
6 awards in the window.
| Award | Agency | Institute or division | Fiscal year | Amount in window | Start | End | Principal investigator | Source |
|---|---|---|---|---|---|---|---|---|
| Accelerating malaria prevention through enhanced analysis of transmission and RTS,S vaccination in Malawi | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $1,554,927 | May 15, 2024 | April 30, 2029 | MATHANGA, DON P | reporter.nih.gov |
| CAPACITY BUILDING FOR HEALTH PROFESSION EDUCATION AND RESEARCH IN MALAWI (CHEER-MALAWI) | NIH | Fogarty International Center | 2023 | $599,963 | September 1, 2019 | May 31, 2025 | MKANDAWIRE, NYENGO | reporter.nih.gov |
| Malawi HIV Implementation Research Scientist Training Program (MHIRST) | NIH | Fogarty International Center | 2025 | $304,400 | May 15, 2015 | March 31, 2030 | MWAPASA, VICTOR | reporter.nih.gov |
| DIRECT: Enhancing Bioethics Capacities at Kamuzu University of Health Sciences (KUHeS) | NIH | Fogarty International Center | 2025 | $278,212 | September 22, 2025 | March 31, 2030 | MANDA_TAYLOR, LUCINDA | reporter.nih.gov |
| Malawian Program for Mental Health Research Training (WARMHEART) | NIH | Fogarty International Center | 2025 | $266,442 | September 1, 2020 | May 31, 2030 | KULISEWA, KAZIONE RADSON | reporter.nih.gov |
| Informing optimal dosing of the future antimalarial, artemether-lumefantrine plus amodiaquine, in key neglected target populations of children with severe acute malnutrition and adults living with HIV | NIH | Fogarty International Center | 2024 to 2025 | $217,720 | September 1, 2024 | August 31, 2029 | BANDA, CLIFFORD GEORGE | reporter.nih.gov |
Funding by fiscal year
| Fiscal year | NIH awards | NIH amount | NSF awards | NSF amount |
|---|---|---|---|---|
| 2025 | 5 | $1,712,515 | 0 | $0 |
| 2024 | 2 | $909,186 | 0 | $0 |
| 2023 | 1 | $599,963 | 0 | $0 |
Open federal funding opportunities
From Grants.gov: notices that funded awards in this table, and open notices on the same agency and assistance listing.
| Open opportunity | Number | Agency | Listing | Closes | Award ceiling | Why it matches |
|---|---|---|---|---|---|---|
| Global Brain and Nervous System Disorders Research Across the Lifespan - Exploratory Grants | PAR-26-144 | NIH | 93.989 | November 15, 2026 | Not listed | Same assistance listing 93.989 as 5 awards here |
| Ethical, Legal and Social Implications (ELSI) Small Research Grant (R03 Clinical Trial Optional) | PAR-25-370 | NIH | 93.989 | November 16, 2026 | $50,000 | Same assistance listing 93.989 as 5 awards here |
| Ethical, Legal and Social Implications (ELSI) Exploratory/Developmental Research Grant (R21 Clinical Trial Optional) | PAR-25-369 | NIH | 93.989 | November 18, 2026 | Not listed | Same assistance listing 93.989 as 5 awards here |
| Emerging Global Leader Award (K43 Independent Clinical Trial Required) | PAR-24-295 | NIH | 93.989 | December 3, 2026 | Not listed | Same assistance listing 93.989 as 5 awards here |
| Emerging Global Leader Award (K43 Independent Clinical Trial Not Allowed) | PAR-24-296 | NIH | 93.989 | December 3, 2026 | Not listed | Same assistance listing 93.989 as 5 awards here |
| International Research Scientist Development Award (IRSDA) | PAR-28-040 | NIH | 93.989 | February 9, 2027 | Not listed | Same assistance listing 93.989 as 5 awards here |
| Digital Health Technology and Reciprocal Innovation to Improve Clinical and Public Health Outcomes | PAR-28-039 | NIH | 93.989 | February 11, 2027 | Not listed | Same assistance listing 93.989 as 5 awards here |
| Implementation and Evaluation of Databases to Examine AIDS | RFA-AI-28-025 | NIH | 93.989 | May 27, 2027 | Not listed | Same assistance listing 93.989 as 5 awards here |
| Hubs of Interdisciplinary Research and Training in Global Environmental and Occupational Health (GEOHealth) | RFA-TW-28-001 | NIH | 93.989 | September 22, 2027 | Not listed | Same assistance listing 93.989 as 5 awards here |
| Emerging Global Leader Award (K43) | PAR-28-070 | NIH | 93.989 | October 12, 2027 | Not listed | Same assistance listing 93.989 as 5 awards here |
| Dissemination and Implementation Research in Health (R21 Clinical Trial Optional) | PAR-25-143 | NIH | 93.989 | January 7, 2028 | Not listed | Same assistance listing 93.989 as 5 awards here |
| Dissemination and Implementation Research in Health (R03 Clinical Trial Not Allowed) | PAR-25-233 | NIH | 93.989 | January 7, 2028 | Not listed | Same assistance listing 93.989 as 5 awards here |
| Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp Clinical Trial Optional) | PA-26-001 | NIH | 93.989 | November 30, 2028 | Not listed | Same assistance listing 93.989 as 5 awards here |
| NIH Collaborative International Research Project (Parent PF5 Clinical Trial Optional) | PA-26-002 | NIH | 93.989 | May 7, 2029 | Not listed | Same assistance listing 93.989 as 5 awards here |
| Centers for AIDS Research (CFAR) and Developmental Centers for AIDS Research (D-CFAR) (P30 Clinical Trial Not Allowed) | PAR-28-090 | NIH | 93.989 | May 25, 2029 | Not listed | Same assistance listing 93.989 as 5 awards here |
| Infectious Diseases Clinical Trials Network (IDCTN) (UM1 Clinical Trial Required) | RFA-AI-27-002 | NIH | 93.855 | November 10, 2026 | Not listed | Same assistance listing 93.855 as 1 award here |
| Clinical Research Network on Antimicrobial Resistance (UM1 Clinical Trial Required) | RFA-AI-27-005 | NIH | 93.855 | November 10, 2026 | Not listed | Same assistance listing 93.855 as 1 award here |
| Ethical, Legal and Social Implications (ELSI) Research (R01 Clinical Trial Optional) | PAR-25-371 | NIH | 93.855 | November 18, 2026 | Not listed | Same assistance listing 93.855 as 1 award here |
| Intervention Research to Improve Native American Health (R01 Clinical Trial Optional) | PAR-25-379 | NIH | 93.855 | January 7, 2027 | Not listed | Same assistance listing 93.855 as 1 award here |
| HIV/AIDS Clinical Trials Network Leadership and Operations Centers | RFA-AI-28-001 | NIH | 93.855 | January 22, 2027 | Not listed | Same assistance listing 93.855 as 1 award here |
Topics of its NIH awards
- Clinical Research
- Translational Research
- Clinical Trials and Supportive Activities
- Infectious Diseases
- Mental Health
- Antimicrobial Resistance
- Emerging Infectious Diseases
- Malaria
- Nutrition
- Orphan Drug
- Rare Diseases
- Vector-Borne Diseases
Updated November 4, 2026. Read from NIH RePORTER ExPORTER and NSF Award Search. Published by NIH and NSF as U.S. government data. NIH awards are fiscal years 2021 to 2025 (NIH files published to 2026-07-09); NSF awards are fiscal years 2022 to 2026 (NSF files published to 2026-11-04). NIH amounts are the total cost of each fiscal year in the window; NSF amounts are the funds obligated in the window. Organizations are matched on the UEI. Open opportunities come from Grants.gov and match on agency and assistance listing number, and on the notice number NIH prints on an award. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.